Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Status
- RECRUITING
- Phase
- NA
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
- Status
- UNKNOWN
- Phase
- N/A
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Long Term Safety Study of Degarelix in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
- Status
- UNKNOWN
- Phase
- N/A
Efavirenz in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Validation of a Screening Tool in Geriatric Oncology
- Status
- COMPLETED
- Phase
- NA
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy
- Status
- WITHDRAWN
- Phase
- NA
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
- Status
- UNKNOWN
- Phase
- N/A